Profound Medical PROF Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.1%+3.4pp | 70.8%+4.9pp | 72.5%+10.4pp | 69.4%+8.3pp | 67.6%+7.7pp | |
| Operating margin | -202.6%+104pp | -256.3%+53.3pp | -295.4%+88.5pp | -357.4%+55.8pp | -306.4%+123pp | |
| Net margin | -206.8%+62.6pp | -264.4%-4.0pp | -275.2%+85.5pp | -344%+36.5pp | -269.4%+138pp | |
| EBITDA margin | -199.9%+99.4pp | -252.8%+48.0pp | -290.6%+82.2pp | -351%+49.1pp | -299.3%+116pp | |
| Returns | ||||||
| Return on equity | -70.6%-4.2pp | -67.1%-6.4pp | -125.2%— | -104.2%— | -66.4%— | |
| Return on assets | -57.9%— | -57.6%-8.9pp | —— | —— | —— | |
| Return on invested capital | -295.1%— | -374.1%-92.8pp | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.3×— | 0.2×0.0× | —— | —— | —— | |
| Inventory turnover | 0.7×-0.4× | 0.7×+0.1× | —— | —— | 1.1×— | |
| Liquidity | ||||||
| Current ratio | 6.6×-4.8× | 12.5×+2.0× | 4.2×— | 8.5×— | 11.3×— | |
| Quick ratio | 5.7×-4.3× | 11.2×+1.5× | 3.3×— | 7.1×— | 10×— | |
| Cash ratio | 4.7×-4.0× | 9.8×+1.5× | 2.5×— | 6.1×— | 8.8×— | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×— | 0.1×— | 0.1×— | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×— | 0.1×— | 0.1×— | |
| Interest coverage | -38×-12.4× | -38.6×-15.5× | -34×-9.4× | -31.6×-7.9× | -25.6×+2.5× | |
| Per Share | ||||||
| Book value per share | $1.64-3.2% | $2.20-9.9% | $1.07-14.7% | $1.31-17.9% | $1.69-9.8% | |
| Valuation | ||||||
| Market capitalization | $241.65M+30.7% | $278.37M+23.4% | $146.96M-24.6% | $186.33M-9.1% | $174.83M-16.1% | |
| Enterprise value | $198.81M+28.7% | $223.36M+27.1% | $126.89M— | $155.95M— | $133.28M— | |
| Price / sales | 12.8×-2.8× | 17.3×-3.8× | 10.3×-13.2× | 15.7×-12.4× | 14.7×-15.7× | |
| Price / book | 4.1×-0.6× | 4.2×+0.5× | 4.6×-1.8× | 4.7×-0.5× | 3.4×-1.1× | |
| EV / sales | 10.6×-2.5× | 13.9×-2.6× | 8.9×— | 13.2×— | 11.2×— | |
| Earnings yield | -16.1%+5.9pp | -15.3%-3.0pp | -26.8%-11.4pp | -21.9%-8.4pp | -18.3%-4.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Profound Medical's profit margins?
- Profound Medical (PROF) runs a 71.1% gross margin and a -202.6% operating margin, with a -206.8% net margin.
- Where do Profound Medical's ratios come from?
- Every ratio is computed from Profound Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
